Molecular Templates, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2017

Reconciliation of Numerator and Denominator

A reconciliation of the numerator and denominator used in the calculation is as follows (in thousands, except per share amounts):

	Three Months Ended March 31,
	2017			2016
Numerator:
Net loss	$	(5,074	)	$	(7,852	)

Denominator:
Weighted average common shares outstanding		71,575			71,488

Net loss per share
Basic	$	(0.07	)	$	(0.11	)
Diluted	$	(0.07	)	$	(0.11	)

Warrants, Options and Purchase Rights Excluded from Computation of Diluted Net Loss Per Share

The following outstanding warrants, options and purchase rights under the Company’s 2004 Employee Stock Purchase Plan (“2004 Purchase Plan”) were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an antidilutive effect (in thousands):

	Three Months Ended March 31,
	2017		2016
Shares issuable upon exercise of warrants		8,300		8,300
Shares issuable upon exercise of stock options		10,827		11,561
Shares issuable related to the 2004 Purchase Plan		20		39